Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study

Sarah C. Clement, Chantal A. Lebbink, Mariëlle S. Klein Hesselink, Jop C. Teepen, Thera P. Links, Cecile M. Ronckers, Hanneke M. van Santen*, on behalf of the DCOG-LATER Study Group, The Netherlands and the Dutch (Pediatric) Thyroid Cancer Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: Childhood cancer survivors (CCS) are at increased risk to develop differentiated thyroid cancer predominantly after radiotherapy (subsequent DTC). It is insufficiently known whether subsequent DTC in CCS has a different presentation or outcome than sporadic DTC. Methods: Patients with subsequent DTC (n = 31) were matched to patients with sporadic DTC (n = 93) on gender, age and year of diagnosis to compare presentation and DTC outcomes. Clinical data were collected retrospectively. Results: Among the CCS with subsequent DTC, all but one had received chemotherapy for their childhood cancer, 19 (61.3%) had received radiotherapy including the thyroid region, 3 (9.7%) 131I-MIBG and 8 (25.8%) had received treatment with chemotherapy only. Subsequent DTC was detected by surveillance through neck palpation (46.2%), as a self-identified mass (34.6%), or by chance. Among sporadic DTC patients, self detection predominated (68.8%). CCS with subsequent DTC tended to have on average smaller tumors (1.9 vs 2.4 cm, respectively, (P = 0.051), and more often bilateral (5/25 (60.0%) vs 28/92 (30.4%), P = 0.024). There were no significant differences in the occurrence of surgical complications, recurrence rate or disease-related death. Conclusion: When compared to patients with sporadic DTC, CCS with subsequent DTC seem to present with smaller tumors and more frequent bilateral tumors. Treatment outcome seems to be similar. The finding that one-third of subsequent DTC cases had been treated with chemotherapy only needs further investigation. These results are important for the development of surveillance programs for CCS at risk for DTC and for treatment guidelines of subsequent DTC.

Original languageEnglish
Pages (from-to)169-180
Number of pages12
JournalEuropean Journal of Endocrinology
Volume183
Issue number2
DOIs
Publication statusPublished - Aug 2020

Cite this

Clement, S. C., Lebbink, C. A., Klein Hesselink, M. S., Teepen, J. C., Links, T. P., Ronckers, C. M., ... on behalf of the DCOG-LATER Study Group, The Netherlands and the Dutch (Pediatric) Thyroid Cancer Consortium (2020). Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study. European Journal of Endocrinology, 183(2), 169-180. https://doi.org/10.1530/EJE-20-0153